Business ❯ Finance ❯ Corporate Finance

Pharmaceutical Industry

Novo Nordisk Pfizer Eli Lilly AstraZeneca Company Performance Cipla Merck Johnson & Johnson Vertex Pharmaceuticals Sun Pharmaceutical Industries

Pfizer Posts Higher Q1 Sales but Lower Profit, Raising Fresh Questions About Its Dividend

Income investors face a tough tradeoff over thin coverage of the payout.

Vertex Posts Mixed Quarter as Profit Beats, Sales Miss and Outlook Holds

AstraZeneca Tops Q1 Forecasts, Reaffirms 2026 Outlook as Oncology Fuels Growth

AstraZeneca Posts Strong 2025 Results, Sees Further Growth in 2026

AbbVie Beats Q4 and Raises 2026 Outlook as Shares Fall on Aesthetics, Oncology Concerns

Mankind Pharma’s Q3 Profit Climbs on Chronic-Drug Demand as Shares Slide on Margin Concerns

Sun Pharma Q3 Profit Up 16% on Innovative Medicines, Margin Expands

J&J Beats Q4 Forecasts and Sets 2026 Guidance Above Wall Street

Pfizer Sets 2026 Targets Below Wall Street as COVID Sales Fade, Patent Pressure Builds

Over 200 Indian Firms Report Today as LIC, Lupin Shine and Infosys Sets Buyback Record Date

Mankind Pharma Posts Fourth Straight Profit Decline as GST Transition Disrupts OTC Sales

Pfizer Tops Q3 Forecasts, Raises Profit Outlook

BioNTech Raises 2025 Sales Outlook After $1.5 Billion BMS Payment

GSK Lifts 2025 Guidance After Strong Quarter, Says Tariff Risks Covered

Dr Reddy's Q2 Profit Up 14% on Branded Strength as North America Falls 13%

Novo Nordisk Shares Slide 65% From Peak as Analysts Flag 40% Upside

Pfizer Beats Q2 Estimates and Raises 2025 Profit Forecast

Aurobindo Pharma Declares Rs4 Interim Dividend Following 10% Q1 Profit Decline

Sun Pharma Q1 Revenue Climbs 9.4% as One-Off Costs Weigh on Profit

Torrent Pharma Delivers 11% Q1 Revenue Growth as Citi Raises Price Target